Going Viral: The Role of Remdesivir in COVID-19 - Online CME Course
In the past year multiple different medications have been evaluated for use in COVID-19. Remdesivir is an antiviral that showed promise in SARS-CoV-2 infections early in 2020 then was subsequently FDA-approved for its use in COVID-19 in late 2020. This presentation will review the data behind remdesivir’s use and describe an ideal patient population for remdesivir.
See the "Program" tab to view the video. No need to register unless you want to claim credit ($10 fee to claim .50 CME credit hours)
Healthcare workers of all specialties who are being impacted by COVID-19, including physicians, research scientists, physician assistants, nurse practitioners, nurses, and anyone with a particular interest in prevention, treatment, and patient care.
Upon completion of this activity you will be able to:
- Describe remdesivir's mechanism of action against SARS-CoV-2
- Identify optimal adult patient populations for remdesivir
- Outline future directions for remdesivir in COVID-19 treatment
Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.
You are invited to watch the video at no cost:
To Register and Claim Credit for this segment (.50 hours / $10), follow these steps:
- Select Register Now.
- Complete the checkout process.
- Once you complete your registration, click the “view course page” hyperlink.
- Select the Start button, and then select Start Course button at the bottom of the screen.
- Complete the quiz, fill out the evaluation and claim credit.
If you need additional assistance, contact us or call our toll-free number, 1-800-323-2688.
|Devyani Lal, M.D.|
Associate Dean, Mayo Clinic School of
Continuous Professional Development
Professor of Otolaryngology,
College of Medicine
Chair, Division of Rhinology
Mayo Clinic in Arizona
Jennifer (Jen) L. Adema, Pharm.D., R.Ph.
Mayo Clinic School of Health Sciences
Mayo Clinic in Minnesota
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of .50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
The American Osteopathic Association designates this program for a maximum of .50 AOA Category 2-A credits.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 AOA Category 2-A
- 0.50 Attendance